ADHD medicine supply issues – advice for patients/parents and carers
Published: 17/10/2023 14:25ADHD medicine supply issues – advice for patients/parents and carers
There are national issues with supplies of some ADHD medicines which we expect to remain until January 2024. The affected medicines are listed below. If you, or your child, is prescribed one or more of these medicines, you should only order a repeat prescription when you have 14 days medication remaining. If your medicine is not available, your GP and community pharmacy will work together to help you, getting in touch with your specialist provider if needed. GP practices and community pharmacies have been given detailed information on the current supply issues, with advice on the steps they should take.
Please do not order repeat prescriptions if you have more than 14 days remaining, as this may worsen the supply issues.
The supply issues have come about because of an increase in global demand for these medicines and because of manufacturing issues. If you have any further questions, you should speak to your GP or other members of the clinical team providing your care.
At present the affected medicines are as follows:
| Methylphenidate | Lisdexamfetamine | Guanfacine |
|
Equasym XL® 10, 20 and 30 mg capsules
Xaggitin XL® 18 and 36 mg prolonged-release tablets
Concerta XL® 54 mg prolonged-release tablets
Xenidate XL® 27 mg prolonged-release tablets |
Elvanse® 20mg, 30mg, 40mg, 50mg, 60mg and 70 mg capsules Elvanse® Adult 30mg, 50mg, and 70 mg capsules |
Intuniv® 1mg, 2mg, 3mg and 4 mg prolonged-release tablets |